NORTHERN TRUST CORP - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 31 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$102,544
+158.6%
132,0590.0%0.00%
Q4 2022$39,657
-40.8%
132,0590.0%0.00%
Q3 2022$67,000
-13.0%
132,059
-0.9%
0.00%
Q2 2022$77,000
-58.2%
133,264
-6.3%
0.00%
Q1 2022$184,000
+14.3%
142,204
+0.9%
0.00%
Q4 2021$161,000
-26.8%
140,999
-1.7%
0.00%
Q3 2021$220,000
-23.6%
143,428
-1.4%
0.00%
Q2 2021$288,000
+7.5%
145,5150.0%0.00%
Q1 2021$268,000
+92.8%
145,515
+129.5%
0.00%
Q4 2020$139,00063,4020.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders